Vivani Medical (NASDAQ:VANI - Get Free Report)'s stock had its "buy" rating reaffirmed by analysts at HC Wainwright in a report issued on Friday,Benzinga reports. They currently have a $4.00 target price on the stock. HC Wainwright's target price indicates a potential upside of 286.47% from the stock's previous close.
Vivani Medical Stock Up 1.5 %
VANI stock traded up $0.02 during trading on Friday, reaching $1.04. The stock had a trading volume of 83,362 shares, compared to its average volume of 171,619. The company has a market capitalization of $61.31 million, a price-to-earnings ratio of -2.30 and a beta of 2.76. Vivani Medical has a one year low of $0.91 and a one year high of $2.15. The company's 50 day moving average is $1.11 and its two-hundred day moving average is $1.20.
Vivani Medical (NASDAQ:VANI - Get Free Report) last released its earnings results on Monday, March 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01). As a group, research analysts predict that Vivani Medical will post -0.41 earnings per share for the current fiscal year.
Insider Activity at Vivani Medical
In related news, Director Gregg Williams bought 44,400 shares of Vivani Medical stock in a transaction dated Monday, April 7th. The stock was purchased at an average cost of $0.99 per share, with a total value of $43,956.00. Following the transaction, the director now directly owns 4,799,200 shares of the company's stock, valued at approximately $4,751,208. The trade was a 0.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last 90 days, insiders purchased 85,400 shares of company stock worth $84,826. 44.30% of the stock is owned by company insiders.
Institutional Investors Weigh In On Vivani Medical
A number of hedge funds have recently modified their holdings of the stock. Wealthedge Investment Advisors LLC purchased a new stake in Vivani Medical in the fourth quarter worth $43,000. Jane Street Group LLC purchased a new stake in Vivani Medical in the 4th quarter worth about $66,000. Northern Trust Corp raised its stake in Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company's stock valued at $83,000 after acquiring an additional 11,540 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Vivani Medical by 4.6% during the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company's stock valued at $401,000 after purchasing an additional 15,008 shares during the last quarter. Institutional investors own 6.78% of the company's stock.
About Vivani Medical
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Read More
Before you consider Vivani Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.
While Vivani Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
